insilTox ApS: Financial statements 2025
CVR: 36996641
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
insilTox ApS (CVR 36996641) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. That is an increase of 42.8% compared with the year before. Equity in the 2025 report amounted to DKK 46,998. The solvency ratio was 60.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 158,376
- Profit/Loss
- DKK 3,502
- Equity
- DKK 46,998
- Total Assets
- DKK 77,771
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 158K | 4K | 47K | 1 |
| 2024 | - | 111K | 4K | 43K | 1 |
| 2023 | - | 209K | -8K | 40K | 1 |
| 2022 | - | 140K | 3K | 47K | 1 |
| 2021 | - | 78K | -28K | 45K | 1 |
Official annual report
How creditworthy is insilTox ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
InsilTox ApS has published its annual report for 2024. Gross profit came to DKK 110,895, and the net result was DKK 3,861.
About insilTox ApS
insilTox ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2015. The company is registered under the industry Anden teknisk rådgivning. The management consists of Svava Osk Jonsdottir. The company is owned by insilTox Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. Equity in the 2025 report amounted to DKK 46,998.